Shutterstock
Spectrum.Life has announced a €17 Million investment round. The round was led by Act Venture Capital with participation from existing investors.
With this investment, Spectrum.Life will continue to drive its vision to change and save as many lives as possible and become the leading Healthtech and digital health partner to insurers, universities, and corporations.
Stuart McGoldrick, Executive Chairman and Founder of Spectrum.Life, commented: “With this fresh investment we can now deliver upon our ambitious plans to be the market leader in digitally delivered healthcare. We are a 2nd Generation digital health provider, and we firmly believe that Spectrum.Life's blend of clinical acumen and successful track record in scaling digital technologies presents a genuine opportunity to revolutionise healthcare. Our goal is to elevate patient satisfaction and outcomes, within a commercially sustainable model that actively contributes to healthcare transformation and, critically, accessibility. This milestone not only marks a significant achievement for Spectrum.Life, but also signals the wider market’s shift towards embracing integrated Healthtech solutions that deliver digital health transformation for insurers, educators and employers.
With a team of experienced clinicians and professionals, Spectrum.Life has recently strengthened its board with Dr. Paula Franklin, former global Chief Medical Officer of Bupa Group, who also chairs the company's Clinical Advisory Board.
Established in 2018, the Company has experienced strong 60% revenue growth in 2023 and is expected to exceed 50% growth again in 2024 with over ¾ of new business coming from outside of Ireland. Since its launch in the UK market in 2020, the Company has built an impressive list of insurance, corporate and university clients and over 50% of revenue in 2024 will be in the UK market.
Spectrum.Life currently looks after 7.2 million individuals in the UK and Ireland, across multiple insurers, 3000 corporate clients and 50 UK universities. The Company currently employs over 260 people, including over 125 clinicians, with 50 percent based in the UK. With this investment, Spectrum.Life plans to facilitate the recruitment of over 100 new hires over the next 18 months and accelerate its growth trajectory.
“I am incredibly proud of our exceptional team that Stephen Costello, my co-founder and the Company’s CEO, has built. Their dedication and passion have powered our remarkable journey and enabled us to seize growth opportunities over the past years. We would not be here without them. Equally, the close relationships with our clients and customers are crucial to supply clinical excellence. I must also thank Laya healthcare who have been unwavering supporters of us since our formation. We have launched some new key strategic partnerships this year and are excited about others that will be launching over the coming weeks and months”, McGoldrick continued.
McGoldrick also emphasised fiscal responsibility in expansion plans, stating: “We are building our company in a sustainable way and continued profitability is a core focus. We are thrilled to have the support of our investors and funders as we continue to grow. This funding will allow us to broaden our solutions, and venture into new markets, while maintaining capital efficiency. Our pipeline is exceptionally strong, and we are on course to reach €100 million in revenue by 2028.”